pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked · 1,831 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Marketed
avutometinib potassium + defactinib hydrochloride
Avmapki Fakzynja (avutometinib potassium + defactinib hydrochloride)
Ovarian Cancer
$VSTMVerastem, Inc.
0 catalysts
Phase 3
axicabtagene ciloleucel
Yescarta (axicabtagene ciloleucel)
Diffuse Large B-Cell Lymphoma
B-lymphocyte antigen CD19
$GILDGILEAD SCIENCES, INC.
0 catalysts
Phase 3
azeliragon
Coronavirus Disease 2019 (COVID-19)
← prev
page 41 of 62
next →
131
Pain89
Neurology1
Advanced glycosylation end product-specific receptor
Cantex Pharmaceuticals Inc
0 catalysts
Phase 2
azenosertib
azenosertib [INN]
Endometrial Cancer
$ZNTLZentalis Pharmaceuticals, Inc.
0 catalysts
Phase 1
azercabtagene zapreleucel
Diffuse Large B-Cell Lymphoma
Imugene Ltd
0 catalysts
Phase 2
azerutamig
azerutamig [INN]
Esophageal Cancer
Bristol-Myers Squibb Co
0 catalysts
Marketed
bacillus calmette-guerin [strain Montreal] vaccine
Pacis
Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer)
Shire Pharmaceuticals Inc
0 catalysts
Phase 2
bafisontamab
Bile Duct Cancer (Cholangiocarcinoma)
Epidermal growth factor receptorHepatocyte growth factor receptor
EpimAb Biotherapeutics Inc
0 catalysts
Phase 2
balstilimab
Metastatic Colorectal Cancer
Programmed cell death protein 1
$AGENAGENUS INC
0 catalysts
Phase 1
basroparib
basroparib [INN]
Colorectal Cancer
ST Pharm Co Ltd
0 catalysts
Marketed
belinostat
Beleodaq (belinostat)
Peripheral T-Cell Lymphomas (PTCL)
Acrotech Biopharma Inc
0 catalysts
Phase 3
belzupacap sarotalocan
Uveal Melanoma
$AURAAura Biosciences, Inc.
0 catalysts
Marketed
belzutifan
Welireg (belzutifan)
Renal Cell Carcinoma
Endothelial PAS domain-containing protein 1
$MRKMerck & Co., Inc.
0 catalysts
Phase 2
bemcentinib
Non-Small Cell Lung Cancer
Tyrosine-protein kinase receptor UFO
Oncoinvent ASA
0 catalysts
Preclinical
bendamustine
bendamustine [INN]
Chronic Lymphocytic Leukemia (CLL)
Exinda Therapeutics LLC
0 catalysts
Marketed
bendamustine hydrochloride
Belrapzo (bendamustine hydrochloride)
B-Cell Non-Hodgkin Lymphoma
Eagle Pharmaceuticals Inc
0 catalysts
Phase 2
beroterkib
Solid Tumor
$MOSMOSAIC CO
0 catalysts
Phase 1
besufetamig
besufetamig [INN]
Angioimmunoblastic T-Cell Lymphoma (AITL)/Immunoblastic Lymphadenopathy
Ono Pharmaceutical Co Ltd
0 catalysts
pre_registration
bevacizumab biosimilar
Jobevne (bevacizumab-awwb)
Cervical Cancer
Vascular endothelial growth factor A, long form
Shanghai Henlius Biotech Inc
0 catalysts
Marketed
bexarotene
Targretin (bexarotene)
Cutaneous T-Cell Lymphoma
Bausch Health Americas Inc
0 catalysts
Phase 2
bexmarilimab
Clevegen (bexmarilimab [INN])
Refractory Acute Myeloid Leukemia
Faron Pharmaceuticals Oy
0 catalysts
pre_registration
bezuclastinib
Gastrointestinal Stromal Tumor (GIST)
$COGTCogent Biosciences, Inc.
0 catalysts
Marketed
bicalutamide
Bicalutamide (bicalutamide)
Metastatic Prostate Cancer
Northstar Rx LLC
0 catalysts
Phase 3
bifikafusp alfa + onfekafusp alfa
Nidlegy (bifikafusp alfa [INN] + onfekafusp alfa [INN])
Metastatic Melanoma
Philogen SpA
0 catalysts
Marketed
binimetinib
Mektovi (binimetinib)
Metastatic Melanoma
Array BioPharma Inc
0 catalysts
pre_registration
binimetinib + encorafenib
Braftovi + Mektovi (binimetinib + encorafenib)
Metastatic Colorectal Cancer
$PFEPFIZER INC
0 catalysts
Phase 2
bintrafusp alfa
Bile Duct Cancer (Cholangiocarcinoma)
Programmed cell death 1 ligand 1Transforming growth factor beta
Merck KGaA
0 catalysts
Phase 2
birelentinib
Refractory Chronic Lymphocytic Leukemia (CLL)
Dizal Pharmaceutical Co Ltd
0 catalysts
Phase 2
bisantrene
Zantrene (bisantrene)
Refractory Acute Myeloid Leukemia
Alpha-ketoglutarate-dependent dioxygenase FTO
Racura Oncology Ltd
0 catalysts
Phase 2
bizaxofusp
bizaxofusp [INN]
Recurrent Glioblastoma Multiforme (GBM)
$MDNAFMedicenna Therapeutics Corp.
0 catalysts